MEI Pharma, Inc. (MEIP)

Oncology Corporate Profile

Stock Performance

1.4400
0.0100

3 Month Stock History Chart

HQ Location

11975 El Camino Real, Suite 101
San Diego, CA 92130

Company Description

MEI Pharma (formerly Marshall Edwards Inc.) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. Our programs include a potential best-in-class HDAC inhibitor, Pracinostat, and two isoflavone-based drug candidates, ME-143 and ME-344.

Website: http://www.meipharma.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
pracinostat (+ azacitidine)HDAC inhibitor (oral)Acute Myelogenous Leukemia (AML)IIIHelsinn
ME-344 (+ bevacizumab)mitochondrial inhibitorBreast cancer (HER2+)II
pracinostat (+ azacitidine)HDAC inhibitor (oral)Myelodysplastic Syndrome (MDS)II
pracinostat (+ ruxolitnib)HDAC inhibitor (oral)MyelofibrosisII
ME-401PI3K Delta InhibitorChronic Lymphocytic Leukemia (CLL)I
ME-401P13K delta inhibitorFollicular LymphomaI
ME-143NADH oxidase inhibitorVarious cancer typesI
phenoxodiolNADH oxidase inhibitorVarious cancer typesINovogen
PWT143P13K delta inhibitorVarious cancer typesPreclinical

View additional information on product candidates here »

Source: http://www.meipharma.com/

Recent News Headlines

8/21/2017 06:21 am

8/21/2017 06:21 am

8/21/2017 06:21 am

8/21/2017 06:21 am

8/21/2017 06:21 am

8/2/2017 06:33 am

8/2/2017 06:33 am

8/2/2017 06:33 am

8/2/2017 06:33 am

7/7/2017 06:18 am

7/7/2017 06:18 am

7/7/2017 06:18 am

7/7/2017 06:18 am

7/7/2017 06:18 am

7/3/2017 06:18 am

7/3/2017 06:18 am

7/3/2017 06:18 am

7/3/2017 06:18 am

7/3/2017 06:18 am

6/29/2017 06:19 am

6/22/2017 06:19 am

6/20/2017 06:19 am

6/16/2017 12:22 pm

6/16/2017 12:22 pm

6/16/2017 06:19 am